Abstract Background Neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP),
and total-tau protein (tau) are novel blood biomarkers of neurological injury, and may be …

Background and aims Patients infected with SARS-CoV-2 range from asymptomatic, to mild,
moderate or severe disease evolution including fatal outcome. Thus, early predictors of …

Objective To test the hypotheses that blood biomarkers for nervous system injury, serum
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein …

Background and aims To investigate the prognostic value of blood neurofilament light chain
protein (NfL) levels in the acute phase of coronavirus disease 2019 (COVID-19). Methods …

In critically ill COVID-19 patients, the risk of long-term neurological consequences is just
beginning to be appreciated. While recent studies have identified that there is an increase in …

Objective Given the continued spread of coronavirus 2, the early predictors of coronavirus
disease 19 (COVID‐19) associated mortality might improve patients' outcomes. Increased …

Blood neurofilament light chain (NFL) is proposed to serve as an estimate of disease
severity in hospitalized patients with coronavirus disease 2019 (COVID-19). We show that …

There is emerging evidence for multifarious neurological manifestations of coronavirus
disease 2019 (COVID‐19), but little is known regarding whether they reflect structural …

Brain imaging studies of patients with COVID-19 show evidence of macro-and
microhemorrhagic lesions, multifocal white matter hyperintensities, and lesions consistent …

COVID-19 is associated with various neurological symptoms. Serum neurofilament light
chain (sNfL) is a robust marker for neuroaxonal injury. Recent studies have shown that …